View in EDS

Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer.

Saved in:
Bibliographic Details
Title: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer.
Authors: Pérez-Salvia M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Simó-Riudalbas L; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Llinàs-Arias P; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Roa L; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Setien F; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Soler M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., de Moura MC; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Bradner JE; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Gonzalez-Suarez E; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Moutinho C; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain., Esteller M; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Source: Oncotarget [Oncotarget] 2017 May 29; Vol. 8 (31), pp. 51621-51629. Date of Electronic Publication: 2017 May 29 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28881673
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pérez-Salvia+M%22">Pérez-Salvia M</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Simó-Riudalbas+L%22">Simó-Riudalbas L</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Llinàs-Arias+P%22">Llinàs-Arias P</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Roa+L%22">Roa L</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Setien+F%22">Setien F</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Soler+M%22">Soler M</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22de+Moura+MC%22">de Moura MC</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Bradner+JE%22">Bradner JE</searchLink>; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Suarez+E%22">Gonzalez-Suarez E</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Moutinho+C%22">Moutinho C</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Esteller+M%22">Esteller M</searchLink>; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2017 May 29; Vol. 8 (31), pp. 51621-51629. <i>Date of Electronic Publication: </i>2017 May 29 (<i>Print Publication: </i>2017).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28881673
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.18632/oncotarget.18255
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 51621
    Titles:
      – TitleFull: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pérez-Salvia M
      – PersonEntity:
          Name:
            NameFull: Simó-Riudalbas L
      – PersonEntity:
          Name:
            NameFull: Llinàs-Arias P
      – PersonEntity:
          Name:
            NameFull: Roa L
      – PersonEntity:
          Name:
            NameFull: Setien F
      – PersonEntity:
          Name:
            NameFull: Soler M
      – PersonEntity:
          Name:
            NameFull: de Moura MC
      – PersonEntity:
          Name:
            NameFull: Bradner JE
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Suarez E
      – PersonEntity:
          Name:
            NameFull: Moutinho C
      – PersonEntity:
          Name:
            NameFull: Esteller M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 05
              Text: 2017 May 29
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1949-2553
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 31
          Titles:
            – TitleFull: Oncotarget
              Type: main
ResultId 1